Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2010-01-26
2011-10-04
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S287000
Reexamination Certificate
active
08030320
ABSTRACT:
The present invention relates to compounds of formula I,to the preparation thereof and to the therapeutic use thereof.
REFERENCES:
patent: 7176242 (2007-02-01), John et al.
patent: 1477490 (2004-11-01), None
patent: WO 03/040096 (2003-05-01), None
patent: WO 2004/094430 (2004-11-01), None
patent: WO 2005/058915 (2005-06-01), None
patent: WO 2006/099352 (2006-09-01), None
patent: WO 2006/103088 (2006-10-01), None
Beher, D., et al., Protease Inhibitors as Potential Disease-Modifying Therapeutics for Alzheimer's Disease, Expert Opin. Invest. Drugs, vol. 14, pp. 1385-1409, (2005).
Citron, M., et. al., Strategies for Diease Modification in Alzheimer's Disease, Nature Reviews, vol. 5, (2004), pp. 677-685.
Durham, T. B., et. al., Progress Towards the Discovery and Development of Efficacious BACE inhibitors, Curr. Opin. Drug Disc. Dev., vol. 9, pp. 776-791, (2006).
Ghosh, A. K., et. al., B-Secretase as a Therapeutic Target for Inhibitor Drugs, Current Medicinal Chemistry. vol. 9, pp. 1135-1144, (2002).
Kisfaludy, L., et. al., Rapid and Selective Formylation With Pentafluorophenyl Formate, Synthesis, vol. 5, pp. 510, (1987).
Wiedemann, S., et. al., Primary 1-Arylcyclopropylamines from Aryl Cyanides With Diethylzinc and Titanium Alkoxides, Organic Letters, vol. 5, No. 5, pp. 753-755, (2003).
Ben-David, Y., et. al., Chelate-Assisted, Pd-Catalyzed Efficient Carbonylation of Aryl Chlorides, J. Am. Chem. Soc., (1989), vol. 111, pp. 8742-8744.
Ermolieff, J., et. al., Proteolytic Activation of Recombinant Pro-Memapsin 2 (Pro-B-Secretase) Studied With New Fluorogenic Substrates, Biochemistry, vol. 39, pp. 12450-12456, (2000).
Ku, T. W., et. al., An Alternate Enantiospecific Synthesis of Methyl (S)-7-Tert-Butoxycarbonyl-2,3,4,5-Tetrahydro-4-Methyl-3-Oxo- 1H-1,4-Benzodiazepine-2-Acetate, Tetrahedron Letters, vol. 38, No. 18, pp. 3131-3134, (1997).
Orito, K., et. al., Preparation of Benzolactams by Pd(OAc)2-Catalyzed Direct Aromatic Carbonylation, J. Am. Chem. Soc., (2004), vol. 126, pp. 14342-14343.
Wang, Y-C., et. al., An Efficient Synthesis of Thalifoline, Synthesis, (2002), vol. 15, pp. 2187-2190.
Ferrer, S., et. al., N- and O-Alkylation of Isoquinolin-1-ones in The Mitsunobu Reaction: Development of Potential Drug Delivery Systems, J. Chem. Soc., Perkin Trans. 1, (2002), pp. 335-340.
Selkoe, D. J., et. al., Translating Cell Biology Into Therapeutic Advance's in Alzheimer's Disease, Nature, vol. 399, (1999), pp. A23-A31.
Roggo, S., et. al., Inhibition of BACE, A Promising Approach to Alzheimer's Disease Therapy, Current Topics in Medicinal Chemistry, (2002), vol. 2, pp. 359-370.
Evers Michel
Genevois-Borella Arielle
Karlsson Andreas
Malleron Jean-Luc
McDowell Brian
Sanofi-Aventis
Scully , Scott, Murphy & Presser, P.C.
Wilson James O
LandOfFree
Derivatives of 1-OXO-1,2-dihydroisoquinoline-5-carboxamides... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of 1-OXO-1,2-dihydroisoquinoline-5-carboxamides..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of 1-OXO-1,2-dihydroisoquinoline-5-carboxamides... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4257445